Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (61-70 of 292) with videos related to

Pageof 30
Sort By:
Expert Review of Cardiovascular Therapy|June 25, 2015
Current applications of biomarkers in cardiomyopathiesCaroline J Coats, Wendy E Heywood, Kevin Mills, et al.
JACC. Heart Failure|July 5, 2023
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art ReviewJohn W Ostrominski, Ruby Guo, Perry M Elliott, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 28, 2006
Left ventricular outflow tract obstruction caused by accessory mitral valve tissueRajan Sharma, John Smith, Perry M Elliott, et al.
European Heart Journal|October 7, 2023
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathyEugene Braunwald, Sara Saberi, Theodore P Abraham, et al.
Heart (British Cardiac Society)|September 10, 2013
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic reviewOliver P Guttmann, M Shafiqur Rahman, Constantinos O'Mahony, et al.
Clinical Physiology and Functional Imaging|May 25, 2013
Non-invasive assessment of cardiac output at rest and during exercise by finger plethysmographyChristopher H Critoph, Vimal Patel, Bryan Mist, et al.
European Heart Journal|December 12, 2018
Cardiac manifestations of McArdle diseaseDaniel M Jones, Luis Lopes, Rosaline Quinlivan, et al.
European Journal of Heart Failure|December 23, 2017
Evolving concepts in dilated cardiomyopathyMarco Merlo, Antonio Cannatà, Marco Gobbo, et al.
Molecular Genetics and Metabolism|May 5, 2018
Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapyChristoph Wanner, Dominique P Germain, Max J Hilz, et al.
Circulation. Cardiovascular Imaging|March 17, 2011
Imaging phenotype versus genotype in hypertrophic cardiomyopathyMilind Y Desai, Steve R Ommen, William J McKenna, et al.
Pageof 30

Showing results (61-70 of 292) with videos related to

Sort By:
Pageof 30
Expert Review of Cardiovascular Therapy|June 25, 2015
Current applications of biomarkers in cardiomyopathiesCaroline J Coats, Wendy E Heywood, Kevin Mills, et al.
JACC. Heart Failure|July 5, 2023
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art ReviewJohn W Ostrominski, Ruby Guo, Perry M Elliott, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 28, 2006
Left ventricular outflow tract obstruction caused by accessory mitral valve tissueRajan Sharma, John Smith, Perry M Elliott, et al.
European Heart Journal|October 7, 2023
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathyEugene Braunwald, Sara Saberi, Theodore P Abraham, et al.
Heart (British Cardiac Society)|September 10, 2013
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic reviewOliver P Guttmann, M Shafiqur Rahman, Constantinos O'Mahony, et al.
Clinical Physiology and Functional Imaging|May 25, 2013
Non-invasive assessment of cardiac output at rest and during exercise by finger plethysmographyChristopher H Critoph, Vimal Patel, Bryan Mist, et al.
European Heart Journal|December 12, 2018
Cardiac manifestations of McArdle diseaseDaniel M Jones, Luis Lopes, Rosaline Quinlivan, et al.
European Journal of Heart Failure|December 23, 2017
Evolving concepts in dilated cardiomyopathyMarco Merlo, Antonio Cannatà, Marco Gobbo, et al.
Molecular Genetics and Metabolism|May 5, 2018
Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapyChristoph Wanner, Dominique P Germain, Max J Hilz, et al.
Circulation. Cardiovascular Imaging|March 17, 2011
Imaging phenotype versus genotype in hypertrophic cardiomyopathyMilind Y Desai, Steve R Ommen, William J McKenna, et al.
Pageof 30